{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:18:54Z","timestamp":1792451934233,"version":"4.5.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"4","content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0018281","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T20:50:06Z","timestamp":1301691006000},"page":"e18281","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":112,"title":["Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol"],"prefix":"10.1371","volume":"6","author":[{"given":"Venkatesh L.","family":"Hegde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash S.","family":"Nagarkatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitzi","family":"Nagarkatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,4,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0009-3084(02)00144-5","article-title":"Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects.","volume":"121","author":"R Mechoulam","year":"2002","journal-title":"Chem Phys Lipids"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.04.023","article-title":"Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?","volume":"166","author":"JL Croxford","year":"2005","journal-title":"J Neuroimmunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects.","volume":"42","author":"R Mechoulam","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol--recent advances.","volume":"4","author":"R Mechoulam","year":"2007","journal-title":"Chem Biodivers"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.","volume":"10","author":"DT Wade","year":"2004","journal-title":"Mult Scler"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s00210-004-0871-3","article-title":"Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw.","volume":"369","author":"B Costa","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"9561","DOI":"10.1073\/pnas.160105897","article-title":"The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.","volume":"97","author":"AM Malfait","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1167\/iovs.08-2196","article-title":"Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor.","volume":"49","author":"GI Liou","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","article-title":"The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.","volume":"556","author":"B Costa","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.108.147181","article-title":"Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative\/nitrosative stress, inflammation, and cell death.","volume":"328","author":"H Pan","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"Diagnosis and treatment of autoimmune hepatitis.","volume":"36","author":"AJ Czaja","year":"2002","journal-title":"Hepatology"},{"key":"ref12","first-page":"176","article-title":"Experimental hepatitis and role of cytokines.","volume":"60","author":"G Tiegs","year":"1997","journal-title":"Acta Gastroenterol Belg"},{"key":"ref13","first-page":"17","article-title":"Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.","volume":"50","author":"HF Eggink","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A.","volume":"90","author":"G Tiegs","year":"1992","journal-title":"J Clin Invest"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.21174","article-title":"Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.","volume":"43","author":"B Li","year":"2006","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.179.5.1529","article-title":"T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.","volume":"179","author":"H Mizuhara","year":"1994","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/hep.510240413","article-title":"Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice.","volume":"24","author":"PA Knolle","year":"1996","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1620\/tjem.180.139","article-title":"Midzonal necrosis of the liver after concanavalin A-injection.","volume":"180","author":"M Satoh","year":"1996","journal-title":"Tohoku J Exp Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.4049\/jimmunol.0900547","article-title":"SOCS3 in T and NKT cells negatively regulates cytokine production and ameliorates ConA-induced hepatitis.","volume":"183","author":"M Nakaya","year":"2009","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.4049\/jimmunol.0802810","article-title":"IL-22-dependent attenuation of T cell-dependent (ConA) hepatitis in herpes virus entry mediator deficiency.","volume":"182","author":"C Wahl","year":"2009","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1073\/pnas.76.11.5939","article-title":"Galactosamine-induced sensitization to the lethal effects of endotoxin.","volume":"76","author":"C Galanos","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V96.12.3838","article-title":"Identification of a CD11b(+)\/Gr-1(+)\/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.","volume":"96","author":"V Bronte","year":"2000","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system.","volume":"9","author":"DI Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.180.12.7898","article-title":"Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion.","volume":"180","author":"AS Dugast","year":"2008","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1053\/j.gastro.2008.06.032","article-title":"Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.","volume":"135","author":"LA Haile","year":"2008","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11894-006-0068-7","article-title":"Autoimmune hepatitis: diagnosis, treatment, and prognosis.","volume":"8","author":"BA Luxon","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1002\/hep.21059","article-title":"Autoimmune hepatitis, from mechanisms to therapy.","volume":"43","author":"MP Manns","year":"2006","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/mol.108.047035","article-title":"Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.","volume":"74","author":"VL Hegde","year":"2008","journal-title":"Mol Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/eji.200939486","article-title":"Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.","volume":"39","author":"V Greifenberg","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1002\/eji.200939892","article-title":"Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions.","volume":"39","author":"V Bronte","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/j.1600-6143.2009.02757.x","article-title":"Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1.","volume":"9","author":"V De Wilde","year":"2009","journal-title":"Am J Transplant"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.4049\/jimmunol.181.7.4666","article-title":"Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.","volume":"181","author":"P Sinha","year":"2008","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.","volume":"134","author":"T Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.bjp.0705920","article-title":"Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.","volume":"143","author":"B Costa","year":"2004","journal-title":"Br J Pharmacol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.","volume":"111","author":"K Movahedi","year":"2008","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice.","volume":"181","author":"JI Youn","year":"2008","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1073\/pnas.040566697","article-title":"Critical contribution of liver natural killer T cells to a murine model of hepatitis.","volume":"97","author":"K Takeda","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.clinthera.2007.09.013","article-title":"Oromucosal delta9-tetrahydrocannabinol\/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.","volume":"29","author":"DJ Rog","year":"2007","journal-title":"Clin Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/0269881106060967","article-title":"Cannabidiol monotherapy for treatment-resistant schizophrenia.","volume":"20","author":"AW Zuardi","year":"2006","journal-title":"J Psychopharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ptr.2625","article-title":"Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.","volume":"23","author":"C Scuderi","year":"2009","journal-title":"Phytother Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients.","volume":"21","author":"JM Cunha","year":"1980","journal-title":"Pharmacology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","article-title":"Controlled clinical trial of cannabidiol in Huntington&apos;s disease.","volume":"40","author":"P Consroe","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited.","volume":"22","author":"S Reagan-Shaw","year":"2008","journal-title":"Faseb J"},{"key":"ref44","first-page":"1608","article-title":"Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.","volume":"23","author":"H Mizuhara","year":"1996","journal-title":"Hepatology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm1269","article-title":"Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis.","volume":"11","author":"D Jo","year":"2005","journal-title":"Nat Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI0215841","article-title":"Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.","volume":"110","author":"F Hong","year":"2002","journal-title":"J Clin Invest"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.clim.2009.08.015","article-title":"Forced expression of suppressor of cytokine signaling 3 in T cells protects the development of concanavalin A-induced hepatitis in mice.","volume":"133","author":"S Fushimi","year":"2009","journal-title":"Clin Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1668","article-title":"Regulation of immune responses by L-arginine metabolism.","volume":"5","author":"V Bronte","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.20091474","article-title":"Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.","volume":"207","author":"LE Sander","year":"2010","journal-title":"J Exp Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.4049\/jimmunol.0903519","article-title":"Antigen-specific immunity and cross-priming by epithelial ovarian carcinoma-induced CD11b(+)Gr-1(+) cells.","volume":"184","author":"K Tomihara","year":"2010","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1085\/jgp.200308906","article-title":"Ca2+\/calmodulin modulates TRPV1 activation by capsaicin.","volume":"123","author":"T Rosenbaum","year":"2004","journal-title":"J Gen Physiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0022-3565(25)20744-3","article-title":"Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.","volume":"278","author":"VM Showalter","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1002\/eji.201040667","article-title":"Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties.","volume":"40","author":"VL Hegde","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.4049\/jimmunol.166.10.5889","article-title":"CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death.","volume":"166","author":"D Chen","year":"2001","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0018281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:54:00Z","timestamp":1741118040000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0018281"}},"subtitle":[],"editor":[{"given":"Jacques","family":"Zimmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0018281","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,1]]}}}